Amphiregulin and epiregulin expression in colorectal carcinoma and the correlation with clinicopathological characteristics

Onkologie

Volumn 33, Issue 7, 2010, Pages 353-358

  Li, Xiao Dong ^a   Miao, Su Yu ^a   Wang, Guo Liang ^a   Yang, Li ^a   Shu, Yong Qian ^a   Yin, Yong Mei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Amphiregulin; Colorectal carcinoma; ELISA; Epiregulin; Immunohistochemistry

Indexed keywords

AMPHIREGULIN; EPIREGULIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CANCER INVASION; COLORECTAL CARCINOMA; DISTANT METASTASIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; TISSUE LEVEL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHINA; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPIDERMAL GROWTH FACTOR; FEMALE; GLYCOPROTEINS; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASTIC CELLS, CIRCULATING; PRECANCEROUS CONDITIONS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77954481347     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000315380     Document Type: Article

References (26)

1. Yarden Y, Sliwkowski MX: Untangling the ErbB signalling network. Nat Rev Mol Cell Biol 2001; 2:127-137.
2. Ma L, de Roquancourt A, Bertheau P, Chevret S, Millot G, Sastre-Garau X, Espie M, Marty M, Janin A, Calvo F: Expression of amphiregulin and epidermal growth factor receptor in human breast cancer: analysis of autocriny and stromal-epithelial interactions. J Pathol 2001;194:413-419.
3. Johnson GR, Kannan B, Shoyab M, Stromberg K: Amphiregulin induces tyrosine phosphorylation of the epidermal growth factor receptor and p185erbB2. Evidence that amphiregulin acts exclusively through the epidermal growth factor receptor at the surface of human epithelial cells. J Biol Chem 1993;268:2924-2931.
4. Shirakata Y, Komurasaki T, Toyoda H, Hanakawa Y, Yamasaki K, Tokumaru S, Sayama K, Hashimoto K: Epiregulin, a novel member of the epidermal growth factor family, is an autocrine growth factor in normal human keratinocytes. J Biol Chem 2000;275:5748-5753.
5. Toyoda H, Komurasaki T, Uchida D, Takayama Y, Isobe T, Okuyama T, Hanada K. Epiregulin: A novel epidermal growth factor with mitogenic activity for rat primary hepatocytes. J Biol Chem 1995;270:7495-7500.
6. Toyoda H, Komurasaki T, Uchida D, Morimoto S: Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family. Biochem J 1997;326:69-75. (Pubitemid 27386919)
7. Lee D, Pearsall RS, Das S, Dey SK, Godfrey VL, Threadgill DW: Epiregulin is not essential for development of intestinal tumors but is required for protection from intestinal damage. Mol Cell Biol 2004;24:8907-8916.
8. Plowman GD, Green JM, McDonald VL, Neubauer MG, Disteche CM, Todaro GJ, Shoyab M: The amphiregulin gene encodes a novel epidermal growth factor-related protein with tumorinhibitory activity. Mol Cell Biol 1990;10:1969-1981.
9. Masago K, Fujita S, Hatachi Y, Fukuhara A, Sakuma K, Ichikawa M, Kim YH, Mio T, Mishima M: Clinical significance of pretreatment serum amphiregulin and transforming growth factor-α, and an epidermal growth factor receptor somatic mutation in patients with advanced non-squamous, non-small cell lung cancer. Cancer Sci 2008;99: 2295-2301.
10. Ishikawa N, Daigo Y, Takano A, Taniwaki M, Kato T, Hayama S, Murakami H, Takeshima Y, Inai K, Nishimura H, Tsuchiya E, Kohno N, Nakamura Y: Increases of amphiregulin and transforming growth factor-α in serum as predictors of poor response to gefitinib among patients with advanced non-small cell lung cancers. Cancer Res 2005;65:9176-9184.
11. Yamada M, Ichikawa Y, Yamagishi S, Momiyama N, Ota M, Fujii S, Tanaka K, Togo S, Ohki S, Shimada H: Amphiregulin is a promising prognostic marker for liver metastases of colorectal carcinoma. Clin Cancer Res 2008;14:2351-2356.
12. Nishimura T, Andoh A, Inatomi O, Shioya M, Yagi Y, Tsujikawa T, Fujiyama Y: Amphiregulin and epiregulin expression in neoplastic and inflammatory lesions in the colon. Oncol Rep 2008; 19:105-110.
13. Ciardiello F, Kim N, Saeki T, Dono R, Persico MG, Plowman GD, Garrigues J, Radke S, Todaro GJ, Salomon DS: Differential expression of epidermal growth factor-related proteins in human colorectal tumors. Proc Natl Acad Sci USA 1991;88:7792-7796.
14. Johnson GR, Saeki T, Gordon AW, Shoyab M, Salomon D, Sand Stromberg K: Autocrine action of amphiregulin in a coloncarcinoma cell line and immunocytochemical localization of amphiregulin in human colon. J Cell Biol 1992;118:741-751.
15. Damstrup L, Kuwada SK, Dempsey PJ, Brown CL, Hawkey CJ, Poulsen HS, Wiley HS, Coffey RJ Jr: Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. Br J Cancer 1999;80:1012-1019.
16. Baba I, Shirasawa S, Iwamoto R, Okumura K, Tsunoda T, Nishioka M, Fukuyama K, Yamamoto K, Mekada E, Sasazuki T: Involvement of deregulated epiregulin expression in tumorigenesis in vivo through activated Ki-Ras signalling pathway in human colon cancer cells. Cancer Res 2000;60: 6886-6889.
17. Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Lee DC, Prieto J, Avila MA: Amphiregulin: an early trigger of liver regeneration in mice. Gastroenterology 2005;128:424-432.
18. Brown CL, Meise KS, Plowman GD, Coffey RJ, Dempsey PJ: Cell surface ectodomain cleavage of human amphiregulin precursor is sensitive to a metalloprotease inhibitor. Release of a predominant N-glycosylated 43-kDa soluble form. J Biol Chem 1998;273:17258-17268.
19. Berasain C, Garcia-Trevijano ER, Castillo J, Erroba E, Santamaria M, Lee DC, Prieto J, Avila MA: Novel role for amphiregulin in protection from liver injury. J Biol Chem 2005;280:19012-19020.
20. Michalopoulos GK, Khan Z: Liver regeneration, growth factors, and amphiregulin. Gastroenterology 2005;128:503-506.
21. Castillo J, Erroba E, Perugorria MJ, Santamaria M, Lee DC, Prieto J, Avila MA, Berasain C: Amphiregulin contributes to the transformed phenotype of human hepatocellular carcinoma cells. Cancer Res 2006;66:6129-6138.
22. Willmarth NE, Ethier SP: Autocrine and juxtacrine effects of amphiregulin on the proliferative, invasive, and migratory properties of normal and neoplastic human mammary epithelial cells. J Biol Chem 2006;281:37728-37737.
23. Lee S, Medina D, Tsimelzon A, Mohsin SK, Mao S, Wu Y, Allred DC: Alterations of gene expression in the development of early hyperplastic precursors of breast cancer. Am J Pathol 2007;171: 252-262.
24. Kakiuchi S, Daigo Y, Ishikawa N, Furukawa C, Tsunoda T, Yano S, Nakagawa K, Tsuruo T, Kohno N, Fukuoka M, Sone S, Nakamura Y: Prediction of sensitivity of advanced non-small cell lung cancers to gefitinib (Iressa,ZD1839). Hum Mol Genet 2004;13:3029-3043.
25. Khambata-Ford S, Garrett CR, Meropol NJ, Basik M, Harbison CT, Wu S, Wong TW, Huang X, Takimoto CH, Godwin AK, Tan BR, Krishnamurthi SS, Burris HA 3rd, Poplin EA, Hidalgo M, Baselga J, Clark EA, Mauro DJ: Expression of epiregulin and amphiregulin and K-ras mutation status predict disease control in metastatic colorectal carcinoma patients treated with cetuximab. J Clin Oncol 2007;25:3230-3237.
26. Singh AB, Harris RC: Autocrine, paracrine and juxtacrine signaling by EGFR ligands. Cell Signal 2005;17:1183-1193.